Hand sanitizer recalled for methanol contamination and insufficient ethanol
Medek LLC is recalling M Hand Sanitizer due to FDA analysis finding methanol contamination and ethanol levels below label claims. Approximately 256 bottles distributed in Texas.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: This recall is classified as FDA Class I, which meets the Critical severity threshold. The product contains methanol and has ethanol levels below label claims.
Plain-English summary
M Hand Sanitizer Ethyl Alcohol Antiseptic 80%v/v is being recalled. The 128 oz bottles were manufactured in Mexico by Grupo Plast-Y-Kosas S.A. de C.V. and distributed in Texas by Medek LLC.
FDA analysis found that the product contains methanol and has ethanol levels below the 80% concentration stated on the label. Approximately 256 bottles were distributed, affecting all lot numbers.
The recalled product
- Product
- M Hand Sanitizer Ethyl Alcohol Antiseptic 80%v/v, Topical Solution 128 oz/3,785 mL, Made in Mexico by: Grupo Plast-Y-Kosas S.A. de C.V. Puebla 105 Col. Rodriguez Reynosa, Tam, Mexico C.P. 88630, NDC Code: 77797-001-01, Distributed by: Medek, LLC 315 E. Business Hwy 83 Alamo, TX
- Manufacturer
- MEDEK LLC
- Category
- Drug — Topical Antiseptic
- Hazard
- methanol
- subpotent
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateFentanyl Citrate Sterile Injection Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27